KENDRICK JAMES: Open Payments
NPI 1538522560 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 25 payments from 7 companies in 2025. Trend: 2023 $1,027 · 2024 $514 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $346 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Alkermes, Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, CAPLYTA, INVEGA SUSTENNA, REXULTI, ARISTADA, COBENFY, INGREZZA.
Industry payments across SC — which companies pay providers there.
